Laser fenestration and shape memory polymer embolization of type II endoleaks
The present series yielded a 6-month freedom from AAA growth in approximately 43% of patients. Refractory T2ELs represent a complex subset of patients with aneurysmal disease and, with future procedural refinements, SMP embolization holds promise as a minimally invasive therapy for this disease process.
Authors
- Michael C. Stoner (ORCID: https://orcid.org/0000-0002-0131-4920)
- Joel Kruger (ORCID: https://orcid.org/0000-0002-1170-3372)
- Zachary R. Zottola (ORCID: https://orcid.org/0009-0002-7715-385X)
- Doran Mix (ORCID: https://orcid.org/0000-0001-5562-0336)
- Joshua T. Geiger (ORCID: https://orcid.org/0000-0001-8061-2768)
- Fred J. Clubb
- Baqir J. Kedwai (ORCID: https://orcid.org/0000-0002-6812-9922)
- Staci J. Horn
Institutions
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- University of Rochester Medical Center (US)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
- Texas A&M University (US)
Publication Details
- Journal
- Journal of Vascular Surgery Cases and Innovative Techniques
- Published
- 2025-10-15
- DOI
- https://doi.org/10.1016/j.jvscit.2025.102015
- Primary Topic
- Aortic aneurysm repair treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00